Journal of Cardiac Failure
Volume 16, Issue 10 , Pages 827-834 , October 2010

Right Ventricular Dysfunction is a Strong Predictor of Developing Atrial Fibrillation in Acutely Decompensated Heart Failure Patients, ACAP-HF Data Analysis

This work was presented in part at the 2009 Annual Scientific Session of the American College of Cardiology, Orlando, Florida.

Received 23 February 2010 ,Revised 4 May 2010 ,Accepted 6 May 2010.

References 

  1. Steinberg JS. Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. J Am Coll Cardiol. 2006;48:744–746
  2. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87:VI102–VI110
  3. Greeley H. The Public Health as Affected by Chronic Diseases of the Heart, Kidney and Arteries. Am J Public Health (N Y). 1915;5:705–724
  4. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol. 1996;28:1458–1463
  5. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998;32:695–703
  6. Daubert JC. Introduction to atrial fibrillation and heart failure: a mutually noxious association. Europace. 2004;(5 Suppl 1):S1–S4
  7. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–2925
  8. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992;20:527–532
  9. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039–1045
  10. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 1998;32:197–204
  11. Stevenson WG, Stevenson LW. Atrial fibrillation in heart failure. N Engl J Med. 1999;341:910–911
  12. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol. 2002;13:399–405
  13. Byrne M, Kaye DM, Power J. The synergism between atrial fibrillation and heart failure. J Card Fail. 2008;14:320–326
  14. Heist EK, Ruskin JN. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis. 2006;48:256–269
  15. Hoppe UC. Resynchronization therapy in the context of atrial fibrillation: benefits and limitations. J Interv Card Electrophysiol. 2007;18:225–232
  16. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351:2373–2383
  17. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart. 1997;77:346–349
  18. Bangalore S, Yao SS, Chaudhry FA. Role of right ventricular wall motion abnormalities in risk stratification and prognosis of patients referred for stress echocardiography. J Am Coll Cardiol. 2007;50:1981–1989
  19. Baker BJ, Wilen MM, Boyd CM, Dinh H, Franciosa JA. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol. 1984;54:596–599
  20. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol. 1983;2:217–224
  21. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993;328:981–988
  22. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995;25:1143–1153
  23. de Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998;32:948–954
  24. San Roman JA, Vilacosta I, Rollan MJ, et al. Right ventricular asynergy during dobutamine-atropine echocardiography. J Am Coll Cardiol. 1997;30:430–435
  25. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995;130:1276–1282
  26. Herzog E, Saint-Jacques H, Rozanski A. The PAIN Pathway as a Tool to Bridge the Gap between Evidence and Management of Acute Coronary Syndrome. Crit Pathw Cardiol. 2004;3:20–24
  27. Herzog E, Varley C, Kukin M. Pathway for the Management of Acute Heart Failure. Crit Pathw Cardiol. 2005;4:37–42
  28. Herzog E, Fischer A, Steinberg JS. The Rate Control, Anticoagulation Therapy, and Electrophysiology/Antiarrhythmic Medication Pathway for the Management of Atrial Fibrillation and Atrial Flutter. Crit Pathw Cardiol. 2005;4:121–126
  29. Herzog E, Frankenberger O, Pierce W, Steinberg JS. The SELF Pathway for the Management of Syncope. Crit Pathw Cardiol. 2006;5:173–178
  30. Herzog E, Frankenberger O, Aziz E, et al. A novel pathway for the management of hypertension for hospitalized patients. Crit Pathw Cardiol. 2007;6:150–160
  31. Herzog E, Aziz E, Croitor S, et al. Pathway for the Management of Hyperglycemia in Critical Care Units. Crit Pathw Cardiol. 2006;5:114–120
  32. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;34:730–738
  33. Zannad F. Implications of the ADVANCE study for clinical practice. J Hypertens Suppl. 2008;26:S29–S32
  34. Crijns HJ, Tjeerdsma G, de Kam PJ, et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J. 2000;21:1238–1245
  35. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J. 2002;144:597–607
  36. Klein HO, Bakst A, Kaplinsky E. Pulmonary embolism and atrial fibrillation. Am J Cardiol. 1988;61:498–499
  37. Brown AK, Newton P, Hamilton EA, Anderson V. Recurrent pulmonary thromboembolism presenting with cardiac arrhythmias. Thorax. 1979;34:380–383
  38. Flegel KM. When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg?. CMAJ. 1999;160:1181–1182
  39. Brown KA, Okada RD, Boucher CA, Strauss HW, Pohost GM. Right ventricular ejection fraction response to exercise in patients with coronary artery disease: influence of both right coronary artery disease and exercise-induced changes in right ventricular afterload. J Am Coll Cardiol. 1984;3:895–901
  40. Berger HJ, Johnstone DE, Sands JM, Gottschalk A, Zaret BL. Response of right ventricular ejection fraction to upright bicycle exercise in coronary artery disease. Circulation. 1979;60:1292–1300
  41. Manyari DE, Patterson C, Johnson D, Melendez L, Kostuk WJ, Cape RD. Atrial and ventricular arrhythmias in asymptomatic active elderly subjects: correlation with left atrial size and left ventricular mass. Am Heart J. 1990;119:1069–1076
  42. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol. 1995;76:355–358
  43. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–844
  44. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87:VI94–101
  45. Rigolin VH, Robiolio PA, Wilson JS, Harrison JK, Bashore TM. The forgotten chamber: the importance of the right ventricle. Cathet Cardiovasc Diagn. 1995;35:18–28
  46. Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J. 1997;18:276–280
  47. La Vecchia L, Bedogni F, Castellani A, et al. Assessment of right ventricular function and interstitial fibrosis in idiopathic dilated cardiomyopathy: hemodynamic correlates and prognostic value. G Ital Cardiol. 1998;28:513–523

 See page 833 for disclosure information.

PII: S1071-9164(10)00210-1

doi: 10.1016/j.cardfail.2010.05.004

Journal of Cardiac Failure
Volume 16, Issue 10 , Pages 827-834 , October 2010

Article Tools

* Image Usage & Resolution